Subject: Fw: Dr Mike Yeadon: Introductory statement about serious crimes per Mark Sexton communication
To: [email protected] <[email protected]>
Cc: Mark Sexton

Dear Ben Bates,

I have been asked by former policeman, Mark Sexton (copied) to introduce myself to you & to indicate the fields in which I have unequivocal evidence of criminal activity.

Let me begin my outlining my credentials to have realised that the areas I will outline were incorrect in the first place.

My name is Dr Mike Yeadon. I am the most senior, former “big pharma” & biotech research executive speaking out about several serious crimes in relation to what I call the “Covid era”.

My original training was in Biochemistry & Toxicology, in which I was awarded the strongest first class joint honours degree that the School of Biomedical Sciences had ever awarded at the time (1985, University of Surrey).

Part of my undergraduate training involved research placements at the Chemical Defence Establishment, Porton Down, Wiltshire, where I was a small cog in the long term development of injected antidotes for nerve gas poisoning to protect British troops. I also worked at the then Central Laboratory of the Forensic Sciences Service, Aldermaston, Berkshire, adjacent to the Atomic Weapons Research Establishment. While with the Forensic Science Service, I received training on several precision analytical methods including mass spectrometry, then a highly technically complex method.
As far as I recall, I had security clearance for both establishments. Porton Down, then as now, is a top security facility with an international reputation.

My PhD, in the field of Pharmacology was “On the effect of opiates on respiratory function” (1988) and this was sponsored by the MOD.

After securing my PhD, which gave me a sound training in several additional subdisciplines of biology, chemistry & drug metabolism, I joined the pharmaceutical industry.

I spent 24years with “big pharma”, starting at Wellcome Research Laboratories, where I briefly worked alongside a Dr Patrick Vallance (who became Chief Scientific Advisor to the British Government).

For the longest period, I was in charge of Pfizer’s global research in the field of Allergic & Respiratory Disease Therapeutics. I left Pfizer in 2011, having reached the level of Vice President, because the company had decided to exit their large R&D base in Kent. The parting was cordial. Before leaving, I sought to find new homes for the portfolio of exploratory medicines I had helped create & was gratified that Mylan U.K. Ltd, the world’s second largest generics company, acquired much of my former portfolio soon after I had left.

I later founded & lead as CEO a highly successful biotechnology company, Ziarco Pharma Ltd. Pfizer and four other venture capital firms were investors in my company, which was acquired by Novartis Pharmaceuticals, in 2017.

My accomplishments are considered by some to have been unusual. So much so that a former Pfizer board member & previously worldwide head of R&D, Dr John LaMattina, wrote up my last venture in Forbes, a leading business magazine (February 2017).
https://www.forbes.com/sites/johnlamattina/2017/03/15/turning-pfizer-discards-into-novartis-gold-the-story-of-ziarco/

In summary, I have had a very strong training in multiple disciplines and over 30 years leadership experience in the field of inventing and testing new medicines for respiratory illnesses. I have an excellent analytical background and I can claim to be at least the equal of anyone advising the government in science.

I have no history of “conspiracy theory” or political campaigns or protests. I don’t believe I made a single public comment on anything prior to 2020.

My accomplishments in applied biomedical sciences qualify me to be taken seriously.
I ask that the evidence I marshall is evaluated thoroughly. I am confident in my assessments, which have been tested by dozens of others, internationally well known scientists and doctors.

https://t.me/DrMikeYeadon
Subject: Fw: Dr Mike Yeadon: Introductory statement about serious crimes per Mark Sexton communication To: [email protected] <[email protected]> Cc: Mark Sexton Dear Ben Bates, I have been asked by former policeman, Mark Sexton (copied) to introduce myself to you & to indicate the fields in which I have unequivocal evidence of criminal activity. Let me begin my outlining my credentials to have realised that the areas I will outline were incorrect in the first place. My name is Dr Mike Yeadon. I am the most senior, former “big pharma” & biotech research executive speaking out about several serious crimes in relation to what I call the “Covid era”. My original training was in Biochemistry & Toxicology, in which I was awarded the strongest first class joint honours degree that the School of Biomedical Sciences had ever awarded at the time (1985, University of Surrey). Part of my undergraduate training involved research placements at the Chemical Defence Establishment, Porton Down, Wiltshire, where I was a small cog in the long term development of injected antidotes for nerve gas poisoning to protect British troops. I also worked at the then Central Laboratory of the Forensic Sciences Service, Aldermaston, Berkshire, adjacent to the Atomic Weapons Research Establishment. While with the Forensic Science Service, I received training on several precision analytical methods including mass spectrometry, then a highly technically complex method. As far as I recall, I had security clearance for both establishments. Porton Down, then as now, is a top security facility with an international reputation. My PhD, in the field of Pharmacology was “On the effect of opiates on respiratory function” (1988) and this was sponsored by the MOD. After securing my PhD, which gave me a sound training in several additional subdisciplines of biology, chemistry & drug metabolism, I joined the pharmaceutical industry. I spent 24years with “big pharma”, starting at Wellcome Research Laboratories, where I briefly worked alongside a Dr Patrick Vallance (who became Chief Scientific Advisor to the British Government). For the longest period, I was in charge of Pfizer’s global research in the field of Allergic & Respiratory Disease Therapeutics. I left Pfizer in 2011, having reached the level of Vice President, because the company had decided to exit their large R&D base in Kent. The parting was cordial. Before leaving, I sought to find new homes for the portfolio of exploratory medicines I had helped create & was gratified that Mylan U.K. Ltd, the world’s second largest generics company, acquired much of my former portfolio soon after I had left. I later founded & lead as CEO a highly successful biotechnology company, Ziarco Pharma Ltd. Pfizer and four other venture capital firms were investors in my company, which was acquired by Novartis Pharmaceuticals, in 2017. My accomplishments are considered by some to have been unusual. So much so that a former Pfizer board member & previously worldwide head of R&D, Dr John LaMattina, wrote up my last venture in Forbes, a leading business magazine (February 2017). https://www.forbes.com/sites/johnlamattina/2017/03/15/turning-pfizer-discards-into-novartis-gold-the-story-of-ziarco/ In summary, I have had a very strong training in multiple disciplines and over 30 years leadership experience in the field of inventing and testing new medicines for respiratory illnesses. I have an excellent analytical background and I can claim to be at least the equal of anyone advising the government in science. I have no history of “conspiracy theory” or political campaigns or protests. I don’t believe I made a single public comment on anything prior to 2020. My accomplishments in applied biomedical sciences qualify me to be taken seriously. I ask that the evidence I marshall is evaluated thoroughly. I am confident in my assessments, which have been tested by dozens of others, internationally well known scientists and doctors. 👉 https://t.me/DrMikeYeadon
WWW.FORBES.COM
Turning Pfizer Discards Into Novartis Gold: The Story Of Ziarco
Mike was told in the fall of 2010 that Pfizer was closing the Allergy & Respiratory diseases programs and his own role as the CSO of this group was being eliminated. Rather than seek employment elsewhere, Mike had others ideas.
Like
1
0 Comments 0 Shares 7492 Views